Prominent publications by Uwe Gieler

KOL Index score: 12870

OBJECTIVE: To determine the effects of age related, structured educational programmes on the management of moderate to severe atopic dermatitis in childhood and adolescence.

DESIGN: Multicentre, randomised controlled trial.

SETTING: Seven hospitals in Germany.

PARTICIPANTS: Parents of children with atopic dermatitis aged 3 months to 7 years (n = 274) and 8-12 years (n = 102), adolescents with atopic dermatitis aged 13-18 years (n = 70), and controls (n = 244, n = 83, and n = 50, ...

Also Ranks for: Parents Children |  quality life |  atopic dermatitis |  educational programmes |  controlled trial
KOL Index score: 10051

The contribution of psychological disorders to the burden of skin disease has been poorly explored, and this is a large-scale study to ascertain the association between depression, anxiety, and suicidal ideation with various dermatological diagnoses. This international multicenter observational cross-sectional study was conducted in 13 European countries. In each dermatology clinic, 250 consecutive adult out-patients were recruited to complete a questionnaire, reporting socio-demographic ...

Also Ranks for: Skin Disease |  suicidal ideation |  psychological burden |  13 european countries |  depression anxiety
KOL Index score: 9452

The existing evidence for treatment of atopic eczema (atopic dermatitis, AE) is evaluated using the national standard Appraisal of Guidelines Research and Evaluation. The consensus process consisted of a nominal group process and a DELPHI procedure. Management of AE must consider the individual symptomatic variability of the disease. Basic therapy is focused on hydrating topical treatment, and avoidance of specific and unspecific provocation factors. Anti-inflammatory treatment based on ...

Also Ranks for: Atopic Dermatitis |  guidelines treatment |  selected cases |  disease exacerbation |  topical corticosteroids
KOL Index score: 9311

OBJECTIVE: The objective of this study was to prove training-specific effects in children with atopic dermatitis (AD) and their parents concerning coping with the disease after their participation in a training program. In the 1-year follow-up, the changes in the training group were compared to the changes in a waiting control group while controlling the effects of the changes in severity scores.

METHODS: One hundred eighty-five children aged 8-12 years and their parents participated in ...

Also Ranks for: Atopic Dermatitis |  children parents |  education program |  randomized controlled trial |  psychological child
KOL Index score: 9295

BACKGROUND: The term prurigo has been used for many decades in dermatology without clear definition, and currently used terminology of prurigo is inconsistent and confusing. Especially, itch-related prurigo remains unexplored regarding the epidemiology, clinical profile, natural course, underlying causes, available treatments and economic burden, although burdensome and difficult to treat.

OBJECTIVE: To address these issues, the multicentre European Prurigo Project (EPP) was designed to ...

Also Ranks for: Chronic Prurigo Cpg |  european academy |  consensus conference |  clinical profile |  clear definition
KOL Index score: 9282

To assess the relation among eosinophil-related variables in the peripheral blood, bronchial hyperreactivity, and the presence of atopic dermatitis in children aged 5-14 years, we studied 11 patients with atopic dermatitis alone, six with asthma and atopic dermatitis, 12 with asthma alone, and 12 healthy controls. Eosinophil counts, levels of eosinophil cationic protein, and the capacity of eosinophils to generate leukotriene (LT) C4, as well as bronchial hyperreactivity and a severity ...

Also Ranks for: Atopic Dermatitis |  blood eosinophils |  patients asthma |  bronchial hyperreactivity |  eosinophil counts
KOL Index score: 9067

This guideline was developed as a joint interdisciplinary European project, including physicians from all relevant disciplines as well as patients. It is a consensus-based guideline, taking available evidence from other guidelines, systematic reviews and published studies into account. This second part of the guideline covers antimicrobial therapy, systemic treatment, allergen-specific immunotherapy, complementary medicine, psychosomatic counselling and educational interventions, whereas ...

Also Ranks for: Atopic Eczema |  european guidelines |  allergenspecific immunotherapy |  antipruritic therapy |  systemic treatment
KOL Index score: 8986

The use of nonstandardized and inadequately validated outcome measures in atopic eczema trials is a major obstacle to practising evidence-based dermatology. The Harmonising Outcome Measures for Eczema (HOME) initiative is an international multiprofessional group dedicated to atopic eczema outcomes research. In June 2011, the HOME initiative conducted a consensus study involving 43 individuals from 10 countries, representing different stakeholders (patients, clinicians, methodologists, ...

Also Ranks for: Outcome Measures |  atopic eczema |  topic dermatitis |  clinical signs |  major obstacle
KOL Index score: 8881

Psoriasis is associated with significant physical and psychological burden affecting all facets of a patient's life--relationships, social activities, work and emotional wellbeing. The cumulative effect of this disability may be self-perpetuating social disconnection and failure to achieve a 'full life potential' in some patients. Health-related quality of life studies have quantified the burden of psoriasis providing predominantly cross-sectional data and point-in-time images of ...

Also Ranks for: Psoriasis Quality Life |  psychological humans |  concept clci |  external factors |  patients lives
KOL Index score: 8741

BACKGROUND: Generic instruments measuring health-related quality of life (HRQoL), like EQ5D™, enable comparison of skin diseases with healthy populations and nondermatological medical conditions, as well as calculation of utility data.

OBJECTIVES: To measure HRQoL in patients with common skin diseases and healthy controls across Europe using the EQ5D.

METHODS: This multicentre observational cross-sectional study was conducted in 13 European countries. Each dermatology clinic recruited at ...

Also Ranks for: Skin Diseases |  13 countries |  multicentre study |  illness cross |  leg ulcers
KOL Index score: 8733

The existing evidence for treatment of atopic eczema (atopic dermatitis, AE) is evaluated using the national standard Appraisal of Guidelines Research and Evaluation. The consensus process consisted of a nominal group process and a DELPHI procedure. Management of AE must consider the individual symptomatic variability of the disease. Basic therapy is focused on hydrating topical treatment, and avoidance of specific and unspecific provocation factors. Anti-inflammatory treatment based on ...

Also Ranks for: Atopic Dermatitis |  guidelines treatment |  disease exacerbation |  topical corticosteroids |  proactive therapy
KOL Index score: 8536

This guideline was developed as a joint interdisciplinary European project, including physicians from all relevant disciplines as well as patients. It is a consensus-based guideline, taking available evidence from other guidelines, systematic reviews and published studies into account. This first part of the guideline covers methods, patient perspective, general measures and avoidance strategies, basic emollient treatment and bathing, dietary intervention, topical anti-inflammatory ...

Also Ranks for: Atopic Eczema |  topical treatment |  pruritus severity |  european guidelines |  calcineurin inhibitors
KOL Index score: 8533

OBJECTIVE: To evaluate the German version of the Social Phobia Inventory (SPIN) as a screening device and to report corresponding cut-off scores for different populations.

METHOD: In Study 1, 2043 subjects from a representative sample completed the SPIN. Cut-off values were established on the basis of means and standard deviations. In Study 2, different aspects of validity were examined in a clinical sample comprising 164 subjects, including social phobic individuals, individuals with ...

Also Ranks for: Social Phobia Inventory |  german version |  divergent validity |  anxiety disorders |  sensitivity specificity

Key People For Atopic Dermatitis

Top KOLs in the world
#1
Donald * * *****
atopic dermatitis eczema herpeticum food allergy
#2
Thomas ** ******
atopic dermatitis dendritic cells lupus erythematosus
#3
Jon * *******
atopic dermatitis eczema herpeticum histamine release
#4
Mark ***********
atopic dermatitis eczema herpeticum tacrolimus ointment
#5
Hywel * * ********
atopic eczema cochrane skin basal cell carcinoma
#6
Johnannes ****
atopic eczema west germany histamine release

Uwe Gieler:Expert Impact

Concepts for whichUwe Gielerhas direct influence:Atopic dermatitis,  Atopic eczema,  Dermatological patients,  Skin diseases,  Factitious disorders,  Psychological factors,  Chronic itch,  Multicentre study.

Uwe Gieler:KOL impact

Concepts related to the work of other authors for whichfor which Uwe Gieler has influence:Atopic dermatitis,  Chronic pruritus,  Quality life,  Acne vulgaris,  Skin diseases,  Patients psoriasis,  Hidradenitis suppurativa.


 

Tools

Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile


Klinik für Psychosomatik und Psychotherapie des UKGM, Universitätsklinik, Giessen, Germany, | Clinic for Dermatology, Venerology and Allergology, University Hospital Gießen and Marburg, Location Gießen, Gießen, Germany | Department of Dermatology, Un